SEC Form 4 · accession 0001127602-17-027793
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rosemary A Crane
Director
Period of report
Sep 18, 2017
Accepted (ET)
Sep 20, 2017 · 9:08 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Purchase)F1 | $9.43 | Sep 18, 2017 | A | 30,000 | A | Sep 18, 2018 | Sep 18, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1One third of the option shares vest upon each of the first, second, and third anniversaries of the Transaction Date.